![](https://bloximages.newyork1.vip.townnews.com/wfmz.com/content/tncms/custom/image/b9818ac0-ee9a-11e9-8e9f-a3b831b71481.jpg?resize=600%2C338)
BioVaxys DPX-Based Vaccines Exhibit Robust Efficacy Across Multiple Infectious Diseases
VANCOUVER, BC, Aug. 22, 2024 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) ("BioVaxys" or the "Company") highlights the potential of its novel lipid-in-oil delivery platform, DPX™, across …